PharmaRadar360
PharmaRadar360
Intelligence Layer

Pharma intelligence feed

Latest pharma feed

8,193
Indexed signals
Latest
Coverage mode
All sectors
Active lens

News stream

Latest stories

Showing 140 of 8,193 stories

Track keywords
🇮🇳Industrynatcopharma.co.in

natco records %e2%82%b9705 4 crore consolidated revenue and %e2%82%b9151 3 crore of profit after tax for q3fy26

Natco Pharma· Original source
🇮🇳Industrynatcopharma.co.in

natco records %e2%82%b91463 crore consolidated revenue and %e2%82%b9517 9 crore of profit after tax for q2fy26

Natco Pharma· Original source
🇮🇳Industrynatcopharma.co.in

natco receives tentative approval for erdafitinib tablets generic of balversa from the united states food and drug administration u s fda

Natco Pharma· Original source
🇮🇳Industrynatcopharma.co.in

natco receives approval from central drug standard control organisation cdsco for semaglutide in india

Natco Pharma· Original source
🇮🇳Industrynatcopharma.co.in

natco pharma limited api unit in chennai receives establishment inspection report eir from u s fda

Natco Pharma· Original source
🇮🇳Industrynatcopharma.co.in

natco pharma launches semaglutide generic injection multi dose vials in india at the most affordable price starting from mrp inr 1290

Natco Pharma· Original source
🇮🇳Industrynatcopharma.co.in

natco announces launch of pomalidomide capsules generic of pomalyst in the u s market

Natco Pharma· Original source
🇮🇳Industrynatcopharma.co.in

natco announces launch of its everolimus tablets 1 mg generic of zortress

Natco Pharma· Original source
🇮🇳Industrynatcopharma.co.in

legal update regarding risdiplam

Natco Pharma· Original source
🇮🇳Industrynatcopharma.co.in

intimation under regulation 30 of sebi listing obligations and disclosure requirements regulations 2015 2

Natco Pharma· Original source
🇮🇳Industrynatcopharma.co.in

disclosure under regulation 30 of the sebi listing obligations and disclosure requirements regulations 2015

Natco Pharma· Original source
🇮🇳Industrynatcopharma.co.in

adcock ingram completes delisting from jse natco pharma acquires 35 75 stake

Natco Pharma· Original source
🇮🇳Industrynatcopharma.co.in

6203

Natco Pharma· Original source
🇮🇳Industrynatcopharma.co.in

Home page

Natco Pharma· Original source
🇬🇧Regulatorygov.uk

Field Safety Notices: 1 May 2026

MHRA UK· Original source
🇬🇧Regulatorygov.uk

Decision: Medical devices given exceptional use authorisations

MHRA UK· Original source
🇯🇵Industrynippon-shinyaku.co.jp

第18回「日本新薬こども文学賞」 最優秀賞作品決定

Nippon Shinyaku News· Original source
🇯🇵Regulatorypmda.go.jp

[KOKUSAI]PMDA-ATC Learning videos have been updated

PMDA Japan· Original source
🇯🇵Industrysanten.com

「健康経営優良法人2026(大規模法人部門)」に認定

Santen Pharmaceutical News· Original source
🇯🇵Industrysanten.com

S&P GlobalによるSustainability Yearbook Member 2026に選定

Santen Pharmaceutical News· Original source
🇯🇵Industrysanten.com

Santen中国、5つの緑内障点眼薬について、中国本土における独占的な流通および販売促進に関する契約を締結

Santen Pharmaceutical News· Original source
🇯🇵Industrysanten.com

後天性眼瞼下垂治療剤「アップニーク®ミニ点眼液0.1%」発売のお知らせ

Santen Pharmaceutical News· Original source
🇯🇵Industrysanten.com

役員人事に関するお知らせ

Santen Pharmaceutical News· Original source
🇯🇵Industrysanten.com

<花粉症に対する意識調査> 花粉症で「パフォーマンスに影響あり」は8割以上 「初期療法(早期治療)」を正しく知っている人の半数以上は「毎年実施」 ~眼科医と気象予報士が解説、花粉飛散期前の対策で春をより快適に~

Santen Pharmaceutical News· Original source
🇯🇵Industrysanten.com

アフリベルセプト硝子体内注射用キット40 mg/mL「バイエル」の発売予定について

Santen Pharmaceutical News· Original source
🇺🇸Researchnewsroom.clevelandclinic.org

Melanoma Monday: Tips to Spot Skin Cancer Early

Cleveland Clinic Main Campus· Original source
🇯🇵Industrykifu-shinsei.jp

2026年度「参天製薬 奨学寄付プログラム」の応募を開始いたしました

Santen Pharmaceutical News· Original source
🇺🇸Industrybiomarin.com

Monica Mann Reflects on a Life Dedicated to Healthcare Transformation

BioMarin Pharmaceutical· Original source
🇬🇧Regulatorygov.uk

Field Safety Notices: 20 to 24 April 2026

MHRA UK· Original source
🌍Industryorchestrabiomed.com

Strengthening AVIM Therapy’s Regulatory Pathway: A Second FDA Breakthrough Device Designation

Orchestra BioMed· Original source
🇬🇧Regulatorygov.uk

Decision: Orphan registered medicinal products

MHRA UK· Original source
🇬🇧Regulatorygov.uk

Nasal decongestant sprays and drops containing xylometazoline hydrochloride / oxymetazoline hydrochloride: increased risk of rebound congestion, rhinitis medicamentosa, and tachyphylaxis with overuse

MHRA UK· Original source
🇺🇸Industrynews.abbvie.com

Allergan Aesthetics Launches Philanthropic Effort in Recognition of Skin Cancer Awareness Month

AbbVie News· Original source
🇺🇸Industrybioreference.com

BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform

BioReference Laboratories· Original source
🇮🇹Industryrecordati.com

Media – RECORDATI: SUMMARY REPORT OF THE VOTES – ORDINARY AND EXTRAORDINARY GENERAL MEETING OF THE SHAREHOLDERS 29.04.2026

Recordati· Original source
🌍Regulatoryeof.gr

“DIAFORM RX”

EOF Greece· Original source
🌍Industryaptose.com

Aptose Biosciences Announces Update on Anticipated Timing of Closing of the Plan of Arrangement with Hanmi Pharmaceutical

Aptose Biosciences· Original source
🇬🇧Regulatorygov.uk

Guidance: The Innovative Devices Access Pathway (IDAP)

MHRA UK· Original source
🌍Regulatorynafdac.gov.ng

Public Alert No. 024/2026 – Alert on Counterfeit Augmentin 625mg Tablets (Batch No. AC3N) in Nigeria

NAFDAC Nigeria· Original source
🇺🇸Industrybristolmyers2016ir.q4web.com

Bristol Myers Squibb Reports First Quarter Financial Results for 2026

Bristol-Myers Squibb News· Original source
🇺🇸Industryinvestor.lilly.com

Lilly reports first-quarter 2026 financial results, raises full year guidance, and highlights momentum of new medicines

Eli Lilly News· Original source
🇺🇸Industrymerck.com

Merck & Co., Inc., Rahway, N.J., USA Announces First-Quarter 2026 Financial Results; Highlights Significant Regulatory Approvals and Clinical Milestones

Merck & Co. (MSD) News· Original source
🇮🇹Industryrecordati.com

MEDIA – Press release (on “il Sole 24 Ore”) – 2025 final payment dividend

Recordati· Original source
🌍Regulatoryifpma.org

Sixth resumed meeting of the open-ended Intergovernmental Working Group (IGWG 6) on the WHO Pandemic Agreement: PABS instrument

IFPMA Global· Original source
🇨🇭Industryroche.com

Roche to present extensive data showcasing its industry-leading ophthalmology portfolio at ARVO 2026

Roche Newsroom· Original source
🇯🇵Industryotsuka.co.jp

Otsuka Launches "Educational Materials and Resources by Otsuka" for Educators to Support Health Education in Schools Providing Free Digital Health Education Materials on Heat Illness Prevention and Nutrition Education

Otsuka Pharmaceutical· Original source
🇺🇸Researchnewsroom.clevelandclinic.org

Small Ways Calories Add Up in Your Diet

Cleveland Clinic Main Campus· Original source
🇺🇸Researchnewsroom.clevelandclinic.org

Cleveland Clinic Pledges $2.5 Million to Feeding Medina County to Strengthen Food Access

Cleveland Clinic Main Campus· Original source
🌍Regulatorynafdac.gov.ng

Note to Industry on Requirement for Bioequivalence Study

NAFDAC Nigeria· Original source
🇧🇷Regulatoryinterfarma.org.br

Interfarma na Imprensa: Interfarma ressalta importância de previsibilidade regulatória após adiamento da Resolução CMED nº 3/2025

Interfarma Brazil· Original source
🇺🇸Industrybiomarin.com

Tommaso Corio Discusses His Journey from BioMarin Internship to International Impact

BioMarin Pharmaceutical· Original source
🇧🇷Regulatoryinterfarma.org.br

Interfarma destaca papel do acesso sustentável à inovação na edição especial do Global Forum 2026

Interfarma Brazil· Original source
🇧🇷Regulatoryinterfarma.org.br

Interfarma e Correio realizam Summit Propriedade Intelectual na Agenda Pública; confira a agenda

Interfarma Brazil· Original source
🌍Regulatoryacrpnet.org

Defining Leadership for Oneself is Key to Becoming a Leader, ACRP 2026 Panelists Say

ACRP Association· Original source
🇬🇧Regulatoryabpi.org.uk

ABPI celebrates a month of major investment commitments into UK life sciences

ABPI UK· Original source
🌍Regulatoryacrpnet.org

Attendees Encouraged to “Act with Courage, Driven by Purpose” as ACRP 2026 Closes

ACRP Association· Original source
🇪🇸Regulatoryaemps.gob.es

La AEMPS informa del cese de comercialización y la retirada del mercado de Deliplus Men Depil bajo la ducha

AEMPS (Spain)· Original source
🇧🇷Regulatoryinterfarma.org.br

Prorrogação da entrada em vigor da Resolução CMED nº 3/2025 é positiva, avalia Interfarma

Interfarma Brazil· Original source
🇨🇦Industryir.beonemedicines.com

U.S. FDA Grants Priority Review to BeOne Medicines’ TEVIMBRA in First-Line HER2+ GEA

Zymeworks· Original source
🌍Industryadial.com

Adial Pharmaceuticals Advances IP Portfolio with New U.S. Utility Patent Application, Positioning for Potential Market Exclusivity Through 2045

Adial Pharmaceuticals· Original source
🇬🇧Regulatorygov.uk

MHRA Safety Roundup: April 2026

MHRA UK· Original source
🇬🇧Regulatorygov.uk

Good laboratory practice (GLP) for safety tests on chemicals

MHRA UK· Original source
🇺🇸Industryir.codexis.com

Codexis to share RNA manufacturing advances at TIDES USA

Codexis· Original source
🌍Regulatoryargentina.gob.ar

ANMAT cancela la habilitación de la firma REHUE S.A. y prohíbe la comercialización de sus productos

ANMAT Noticias· Original source
🌍Regulatoryargentina.gob.ar

ANMAT suspendió el certificado de buenas prácticas de la firma ELECTRON PLAST S.A. y prohibió la comercialización de productos de terceros con destino a tránsito interjurisdiccional

ANMAT Noticias· Original source
🇺🇸Industrynews.abbvie.com

AbbVie Reports First-Quarter 2026 Financial Results

AbbVie News· Original source
🇮🇹Industryrecordati.com

RECORDATI: THE SHAREHOLDERS’ MEETING APPROVES THE 2025 FINANCIAL STATEMENTS AND THE DIVIDEND OF €1.34 PER SHARE (+5.5% VS. 2024). NEW BOARD OF STATUTORY AUDITORS APPOINTED

Recordati· Original source
🌍Regulatoryeof.gr

Ανακοίνωση σχετικά με την Ευρωπαϊκή Βάση Δεδομένων Ι/Π- EUDAMED

EOF Greece· Original source
🌍Regulatoryeof.gr

Aπαγόρευση διάθεσης και διακίνησης των προϊόντων

EOF Greece· Original source
🌍Regulatoryeof.gr

Eκτέλεση προϋπολογισμού μηνός Μαρτίου 2026

EOF Greece· Original source
🇪🇸Regulatoryaemps.gob.es

La AEMPS adecúa los formatos de antibióticos para alinearlos con las pautas clínicas habituales y evitar su uso inapropiado

AEMPS (Spain)· Original source
🇪🇸Regulatoryaemps.gob.es

Boletín sobre Cosméticos, Biocidas AEMPS y Productos de Cuidado Personal. Enero-marzo 2026

AEMPS (Spain)· Original source
🇸🇬Regulatoryapacmed.org

Across the Codes: Navigating MedTech Compliance Expectations in the Region

APACMed· Original source
🌍Regulatorypharmac.govt.nz

Wegovy and Mounjaro for weight loss not funded

Pharmac New Zealand· Original source
🇬🇧Industrygsk.com

GSK delivers strong Q1 performance and start to 2026

GSK News· Original source
🌍Industryrss.globenewswire.com

GH Research Announces Pricing of $117.5 Million Underwritten Offering

GH Research· Original source
🇺🇸Researchnewsroom.clevelandclinic.org

Why Pickleball Injuries Are So Common

Cleveland Clinic Main Campus· Original source
🇺🇸Researchnewsroom.clevelandclinic.org

Cleveland Clinic Establishes Space Health Center

Cleveland Clinic Main Campus· Original source
🇺🇸Industryir.unither.com

United Therapeutics Corporation Announces Retirement of Professor Raymond Dwek, C.B.E., F.R.S., From Its Board of Directors

United Therapeutics (IR)· Original source
🇨🇦Industryir.bauschhealth.com

Bausch Health Announces First Quarter 2026 Results

Bausch Health (IR News)· Original source
🌍Industryeledon.com

We fact-checked the hype behind the Eledon Pharmaceuticals Type 1 diabetes treatment

Eledon Pharmaceuticals· Original source
🌍Industryorchestrabiomed.com

From Blood Pressure Reduction to Cardiac Function: What New AVIM Therapy Data Signal

Orchestra BioMed· Original source
🇬🇧Industrygsk.com

Bepirovirsen accepted for priority review and granted Breakthrough Therapy Designation by the US FDA

GSK News· Original source
🇺🇸Industrynews.abbvie.com

AbbVie Submits Application to FDA for Upadacitinib (RINVOQ®) for Adults and Adolescents with Severe Alopecia Areata

AbbVie News· Original source
🌍Industrybenitec.com

Benitec Biopharma Announces Oral Presentation of Interim Phase 1b/2a Clinical Study Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 at the 2026 American Society of Gene and Cell Therapy Annual Meeting

Benitec Biopharma· Original source
🇬🇧Regulatorygov.uk

Clinical investigations for medical devices

MHRA UK· Original source
🇺🇸Industrymerck.com

Merck’s Playing with Heart Program Teams Up With Professional Baseball Clubs and Baseball Legends to Help Raise Awareness About LDL-C, Called “Bad” Cholesterol, and How It May Impact the Risk of Heart Attack or Stroke

Merck & Co. (MSD) News· Original source
🇬🇧Regulatorygov.uk

Class 2 Medicines Recall: Amarox Limited, Sertraline 100mg film-coated tablets, EL(26)A/22

MHRA UK· Original source
🌍Regulatoryeof.gr

Γενόσημα Μαρτίου 2026 _ Προτεινόμενες Τιμές προς Διαβούλευση

EOF Greece· Original source
🇪🇸Industryrovi.es

Cuidar de las personas, construir prevención

Laboratorios Rovi· Original source
🌍Regulatoryeof.gr

Ανάκληση των παρτίδων του συνημμένου πίνακα του Ιατροτεχνολογικου προϊόντος, MDD Class IIΙ, 16F Dual—Valved Splittable Sheath Introducer

EOF Greece· Original source
🇬🇧Regulatorygov.uk

Transparency data: MHRA Performance Data

MHRA UK· Original source
🇬🇧Regulatorygov.uk

Corporate report: MHRA Results and Forecast 2025/26; 2026/27

MHRA UK· Original source
🇺🇸Devicesnews.medtronic.com

Medtronic announces CE Mark for Stealth AXiS™ surgical system

Medtronic Global News· Original source
🇯🇵Industrytaiho.co.jp

U.S. Food and Drug Administration Accepts New Drug Application for Zipalertinib for the Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

Otsuka Holdings RSS· Original source
🇯🇵Industrytaiho.co.jp

Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development

Otsuka Holdings RSS· Original source
🌍Industrypetros.com

Shop — Petro's Chili & Chips™

Petros Pharmaceuticals· Original source
🌍Industrypetros.com

Menu — Petro's Chili & Chips™

Petros Pharmaceuticals· Original source
🌍Industrypetros.com

Petro's Chili & Chips™

Petros Pharmaceuticals· Original source
🌍Industrypetros.com

404 Error — Petro's Chili & Chips™

Petros Pharmaceuticals· Original source
🇺🇸Industryinvestor.lilly.com

Lilly reports first-quarter 2026 financial results, raises full year guidance, and highlights momentum of new medicines

Eli Lilly News· Original source
🇺🇸Industrymerck.com

Merck & Co., Inc., Rahway, N.J., USA Announces First-Quarter 2026 Financial Results; Highlights Significant Regulatory Approvals and Clinical Milestones

Merck & Co. (MSD) News· Original source
🇮🇹Industryrecordati.com

MEDIA – Press release (on “il Sole 24 Ore”) – 2025 final payment dividend

Recordati· Original source
🌍Regulatoryifpma.org

Sixth resumed meeting of the open-ended Intergovernmental Working Group (IGWG 6) on the WHO Pandemic Agreement: PABS instrument

IFPMA Global· Original source
🇨🇭Industryroche.com

Roche to present extensive data showcasing its industry-leading ophthalmology portfolio at ARVO 2026

Roche Newsroom· Original source
🇯🇵Industryotsuka.co.jp

Otsuka Launches "Educational Materials and Resources by Otsuka" for Educators to Support Health Education in Schools Providing Free Digital Health Education Materials on Heat Illness Prevention and Nutrition Education

Otsuka Pharmaceutical· Original source
🇺🇸Researchnewsroom.clevelandclinic.org

Small Ways Calories Add Up in Your Diet

Cleveland Clinic Main Campus· Original source
🇺🇸Researchnewsroom.clevelandclinic.org

Cleveland Clinic Pledges $2.5 Million to Feeding Medina County to Strengthen Food Access

Cleveland Clinic Main Campus· Original source
🌍Regulatorynafdac.gov.ng

Note to Industry on Requirement for Bioequivalence Study

NAFDAC Nigeria· Original source
🇧🇷Regulatoryinterfarma.org.br

Interfarma na Imprensa: Interfarma ressalta importância de previsibilidade regulatória após adiamento da Resolução CMED nº 3/2025

Interfarma Brazil· Original source
🇺🇸Industrybiomarin.com

Tommaso Corio Discusses His Journey from BioMarin Internship to International Impact

BioMarin Pharmaceutical· Original source
🇧🇷Regulatoryinterfarma.org.br

Interfarma destaca papel do acesso sustentável à inovação na edição especial do Global Forum 2026

Interfarma Brazil· Original source
🇧🇷Regulatoryinterfarma.org.br

Interfarma e Correio realizam Summit Propriedade Intelectual na Agenda Pública; confira a agenda

Interfarma Brazil· Original source
🌍Regulatoryacrpnet.org

Defining Leadership for Oneself is Key to Becoming a Leader, ACRP 2026 Panelists Say

ACRP Association· Original source
🇬🇧Regulatoryabpi.org.uk

ABPI celebrates a month of major investment commitments into UK life sciences

ABPI UK· Original source
🌍Regulatoryacrpnet.org

Attendees Encouraged to “Act with Courage, Driven by Purpose” as ACRP 2026 Closes

ACRP Association· Original source
🇪🇸Regulatoryaemps.gob.es

La AEMPS informa del cese de comercialización y la retirada del mercado de Deliplus Men Depil bajo la ducha

AEMPS (Spain)· Original source
🇧🇷Regulatoryinterfarma.org.br

Prorrogação da entrada em vigor da Resolução CMED nº 3/2025 é positiva, avalia Interfarma

Interfarma Brazil· Original source
🇨🇦Industryir.beonemedicines.com

U.S. FDA Grants Priority Review to BeOne Medicines’ TEVIMBRA in First-Line HER2+ GEA

Zymeworks· Original source
🌍Industryadial.com

Adial Pharmaceuticals Advances IP Portfolio with New U.S. Utility Patent Application, Positioning for Potential Market Exclusivity Through 2045

Adial Pharmaceuticals· Original source
🇬🇧Regulatorygov.uk

MHRA Safety Roundup: April 2026

MHRA UK· Original source
🇬🇧Regulatorygov.uk

Good laboratory practice (GLP) for safety tests on chemicals

MHRA UK· Original source
🇺🇸Industryir.codexis.com

Codexis to share RNA manufacturing advances at TIDES USA

Codexis· Original source
🌍Regulatoryargentina.gob.ar

ANMAT cancela la habilitación de la firma REHUE S.A. y prohíbe la comercialización de sus productos

ANMAT Noticias· Original source
🌍Regulatoryargentina.gob.ar

ANMAT suspendió el certificado de buenas prácticas de la firma ELECTRON PLAST S.A. y prohibió la comercialización de productos de terceros con destino a tránsito interjurisdiccional

ANMAT Noticias· Original source
🇺🇸Industrynews.abbvie.com

AbbVie Reports First-Quarter 2026 Financial Results

AbbVie News· Original source
🇮🇹Industryrecordati.com

RECORDATI: THE SHAREHOLDERS’ MEETING APPROVES THE 2025 FINANCIAL STATEMENTS AND THE DIVIDEND OF €1.34 PER SHARE (+5.5% VS. 2024). NEW BOARD OF STATUTORY AUDITORS APPOINTED

Recordati· Original source
🌍Regulatoryeof.gr

Ανακοίνωση σχετικά με την Ευρωπαϊκή Βάση Δεδομένων Ι/Π- EUDAMED

EOF Greece· Original source
🌍Regulatoryeof.gr

Aπαγόρευση διάθεσης και διακίνησης των προϊόντων

EOF Greece· Original source
🌍Regulatoryeof.gr

Eκτέλεση προϋπολογισμού μηνός Μαρτίου 2026

EOF Greece· Original source
🇪🇸Regulatoryaemps.gob.es

La AEMPS adecúa los formatos de antibióticos para alinearlos con las pautas clínicas habituales y evitar su uso inapropiado

AEMPS (Spain)· Original source
🇪🇸Regulatoryaemps.gob.es

Boletín sobre Cosméticos, Biocidas AEMPS y Productos de Cuidado Personal. Enero-marzo 2026

AEMPS (Spain)· Original source
🇸🇬Regulatoryapacmed.org

Across the Codes: Navigating MedTech Compliance Expectations in the Region

APACMed· Original source
🌍Regulatorypharmac.govt.nz

Wegovy and Mounjaro for weight loss not funded

Pharmac New Zealand· Original source
🇬🇧Industrygsk.com

GSK delivers strong Q1 performance and start to 2026

GSK News· Original source
🌍Industryrss.globenewswire.com

GH Research Announces Pricing of $117.5 Million Underwritten Offering

GH Research· Original source
🇺🇸Researchnewsroom.clevelandclinic.org

Why Pickleball Injuries Are So Common

Cleveland Clinic Main Campus· Original source
🇺🇸Researchnewsroom.clevelandclinic.org

Cleveland Clinic Establishes Space Health Center

Cleveland Clinic Main Campus· Original source
🇺🇸Industryir.unither.com

United Therapeutics Corporation Announces Retirement of Professor Raymond Dwek, C.B.E., F.R.S., From Its Board of Directors

United Therapeutics (IR)· Original source
🇨🇦Industryir.bauschhealth.com

Bausch Health Announces First Quarter 2026 Results

Bausch Health (IR News)· Original source